Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/23236
Title: Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.
Authors: Segelov, Eva;Underhill, Craig;Prenen, Hans;Karapetis, Christos;Jackson, Christopher;Nott, Louise;Clay, Tim;Pavlakis, Nick;Sabesan, Sabe;Heywood, Ellen;Steer, Christopher;Lethborg, Carrie;Gan, Hui K;Yip, Desmond;Karanth, Narayan;Karikios, Deme;MacIntyre, C Raina
Affiliation: Biosecurity Program, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
Department of Medicine, University of Otago, Dunedin, New Zealand
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia
Department of Medical Oncology, The Canberra Hospital and ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia
Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia
Department of Medical Oncology, Nepean Hospital and Nepean Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
Department of Oncology, Monash University and Monash Health, Melbourne, Victoria, Australia
Border Medical Oncology, Albury-Wodonga Regional Cancer Centre, and University of NSW Rural Clinical School, Albury Campus, Albury, New South Wales, Australia
Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australia
Cancer Services, Monash Health, Melbourne, Victoria, Australia
Department of Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia
Department of Oncology, St John of God Subiaco Hospital and School of Medicine and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia
Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Department of Medical Oncology, Townsville Cancer Centre, Townsville Hospital and Health Services, Townsville, Queensland, Australia
Inclusive Health Research, St Vincent's Health Australia, Melbourne, Victoria, Australia
La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia
Department of Oncology, University Hospital Antwerp, Edegem, Belgium..
Issue Date: 13-May-2020
EDate: 2020-05-13
Citation: JCO oncology practice 2020; online first: 13 May
Abstract: Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.
URI: http://ahro.austin.org.au/austinjspui/handle/1/23236
DOI: 10.1200/OP.20.00229
PubMed URL: 32401686
Type: Journal Article
Subjects: COVID-19
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.